首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Human inhibitor of the first component of complement C1: characterization of cDNA clones and localization of the gene to chromosome 11.
【2h】

Human inhibitor of the first component of complement C1: characterization of cDNA clones and localization of the gene to chromosome 11.

机译:补体第一个成分的人类抑制剂C1:cDNA克隆的表征以及该基因在11号染色体上的定位。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

C1 inhibitor is a heavily glycosylated plasma protein that regulates the activity of the first component of complement (C1) by inactivation of the serine protease subcomponents, C1r and C1s. C1 inhibitor cDNA clones have been isolated, and one of these (pC1INH1, 950 base pairs) has been partially sequenced. Sequence analysis demonstrates that the C1 inhibitor is a member of the serpin "superfamily" of protease inhibitors. In the region sequenced, C1 inhibitor has 22% identity with antithrombin III, 26% with alpha 1-antitrypsin and alpha 1-antichymotrypsin, and 18% with human angiotensinogen. C1 inhibitor has a larger amino-terminal extension than do the other plasma protease inhibitors. In addition, inspection of residues that are invariant among the other protease inhibitors shows that C1 inhibitor differs at 14 of 41 of these positions. Thus, it appears that C1 inhibitor diverged from the group relatively early in evolution, although probably after the divergence of angiotensinogen. Southern blot analysis of BamHI-digested DNA from normal individuals and from rodent-human somatic cell hybrid cell lines (that contain a limited but varied human chromosome complement) was used to localize the human C1 inhibitor gene to chromosome 11.
机译:C1抑制剂是一种高度糖基化的血浆蛋白,可通过失活丝氨酸蛋白酶亚组分C1r和C1s来调节补体(C1)第一组分的活性。已分离出C1抑制剂cDNA克隆,并对其中一个(pC1INH1,950个碱基对)进行了部分测序。序列分析表明,C1抑制剂是蛋白酶抑制剂的丝氨酸蛋白酶抑制剂“超家族”的成员。在测序区域中,C1抑制剂与抗凝血酶III的同源性为22%,与α1-抗胰蛋白酶和α1-抗胰凝乳蛋白酶的同源性为26%,与人血管紧张素原的同源性为18%。 C1抑制剂具有比其他血浆蛋白酶抑制剂更大的氨基末端延伸范围。另外,检查其他蛋白酶抑制剂中不变的残基显示,C1抑制剂在这些位置的41个位置中的14个不同。因此,似乎C1抑制剂在进化上相对较早地脱离了该组,尽管可能在血管紧张素原发散之后。来自正常个体和来自啮齿动物-人类体细胞杂交细胞系(包含有限但变化的人类染色体补体)的BamHI消化的DNA的Southern印迹分析用于将人类C1抑制剂基因定位于11号染色体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号